AHFS Drug Information, Pages 1-1264authority of the Board of Directors of the American Society of Hospital Pharmacists, 1994 - Drugs |
Other editions - View all
Common terms and phrases
24 hours active in vitro adults with normal adverse effects aminoglycoside aminopenicillins amphotericin ampicillin and/or anti-infective antibiotics antihistamines aztreonam bacteria caused by susceptible Cautions cefixime cefonicid cefoperazone cefotaxime cefotetan cefoxitin ceftazidime ceftizoxime ceftriaxone cefuroxime cephalosporins chloramphenicol cilastatin cilastatin sodium clarithromycin clinical clinicians suggest cloxacillin commercially available containing contraindicated creatinine clearances divided doses Dosage and Administration erythromycin excreted fluconazole gentamicin gonococcal gonorrhea gram-negative hepatic hydrochloride hypersensitivity reactions imipenem imipenem and cilastatin infections caused infusion inhibited ketoconazole manufacturer meningitis methicillin mg/kg daily mg/mL mL/minute nafcillin natural penicillins neonates netilmicin normal renal function occur organisms oxacillin parenteral patients receiving penicillin penicillin G potassium penicillin G procaine penicillinase-resistant penicillins Pharmacokinetics plasma pneumoniae prophylaxis reconstituted regimen renal impairment reported reportedly resistant single sodium chloride solutions sterile strains streptococci studies sulfate susceptibility tests tablets terfenadine tetracycline therapy tion toxicity tract infections treatment urinary urine usual dosage water for injection µg/mL